Autopsy report · NCT04381429
Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes
Cause of deathSlow enrollment
“Difficulties of inclusion in this rare pathology”
Life of this trial
- Registered 4 months before it started.
- Ran for about 4 years 5 months before it stopped.
- 38 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Conditions
- Cystic Fibrosis-related Diabetes
- Interventions
- A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP); F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)
- Participants
- 38
- Sites
- 1
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.